MedTrace Logo

Topical GHK-Cu Gel for Acute Skin Wound Healing

NCT07437586 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-27

No results posted yet for this study

Summary

This study will evaluate whether a topical gel containing GHK-Cu (a copper(II)-peptide complex) can safely speed up healing of small, standardized skin wounds in healthy adults compared with a matching vehicle gel.

Participants will receive two small punch-biopsy wounds on the upper arm; each wound will be randomly assigned to receive GHK-Cu gel or vehicle gel under identical dressings. Wounds will be photographed and assessed over 3 weeks, with a follow-up visit to evaluate scar quality.

Conditions

  • Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)

Interventions

DRUG

GHK-Cu Gel (Copper(II)-peptide complex)

topical gel, 0.1% w/w; apply a thin film (approx. 0.5 g) once daily for 14 days.

DRUG

vehicle Gel (placebo comparator)

ehicle Gel (placebo comparator

Sponsors & Collaborators

  • Hudson Biotech

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-02
Primary Completion
2027-02-14
Completion
2028-03-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07437586 on ClinicalTrials.gov